Insider NameBuy/SellCompany NameTickerAmountShares Change
Feb 25, 2025Feb 27, 2025Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$58.1$1M-11.10%
Oct 15, 2024Oct 16, 2024Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$53.5$1M-10.32%
Sep 17, 2024Sep 18, 2024Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$62.45$1M-10.32%
Aug 20, 2024Aug 21, 2024Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$61.4$1M-10.63%
Jul 23, 2024Jul 24, 2024Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$55$1M-10.63%
Jun 18, 2024Jun 20, 2024Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$49.43$494,260-5.61%
May 21, 2024May 22, 2024Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$45.27$905,480-10.63%
Apr 16, 2024Apr 17, 2024Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$38.42$768,390-10.63%
Mar 12, 2024Mar 13, 2024Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$41.96$839,100-11.33%
Feb 27, 2024Feb 28, 2024Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$39.75$794,923-11.33%
Jan 16, 2024Jan 18, 2024Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$36$720,000-11.63%
Dec 12, 2023Dec 14, 2023Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$40.01$800,262-11.63%
Nov 14, 2023Nov 16, 2023Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$39.43$788,670-11.63%
Oct 17, 2023Oct 17, 2023Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$36.52$365,200-6.18%
Sep 19, 2023Sep 19, 2023Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$39.1$390,980-6.18%
Aug 22, 2023Aug 23, 2023Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$42.41$424,070-6.18%
Jul 18, 2023Jul 19, 2023Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$40.43$404,300-6.18%
Jun 21, 2023Jun 22, 2023Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$36$360,000-6.58%
Apr 18, 2023Apr 19, 2023Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$36$360,000-6.58%
Feb 27, 2023Apr 19, 2023Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$49.55$147,854-2.06%
Feb 27, 2023Feb 28, 2023Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$49.55$495,483-6.71%
Feb 16, 2023Feb 22, 2023Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$49.26$141,770-1.90%
Feb 15, 2023Feb 17, 2023Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$48.39$483,940-6.42%
Jan 17, 2023Jan 19, 2023Labarre Michael J.
SVP
CHIEF TECHNICAL OFFICER
SellHalozyme Therapeutics, Inc.HALO$50.46$504,590-6.53%
Dec 13, 2022Dec 13, 2022Labarre Michael J.
SVP
Chief Technical Officer
SellHalozyme Therapeutics, Inc.HALO$58.67$586,675-6.13%
Nov 15, 2022Nov 17, 2022Labarre Michael J.
SVP
Chief Technical Officer
SellHalozyme Therapeutics, Inc.HALO$54.13$541,263-5.78%
Oct 01, 2021Oct 01, 2021Labarre Michael J.
SVP
Chief Technical Officer
SellHalozyme Therapeutics, Inc.HALO$39.93$1M-16.52%
Apr 01, 2021Apr 01, 2021Labarre Michael J.
SVP
Chief Technical Officer
SellHalozyme Therapeutics, Inc.HALO$42.56$1M-18.94%
Mar 01, 2021Mar 02, 2021Labarre Michael J.
SVP
Chief Technical Officer
SellHalozyme Therapeutics, Inc.HALO$45.81$839,364-12.98%
Dec 21, 2020Dec 21, 2020Labarre Michael J.
SVP
Chief Technical Officer
SellHalozyme Therapeutics, Inc.HALO$42.58$510,919-8.90%
Sign in to view more
To unlock more features with more data and insights.
By continuing, you agree to our Terms of Service and Privacy Policy.